Search

List Grid

101 - 110 of 982 Results

  • KFF COVID-19 Vaccine Monitor: March 2023

    Poll Finding

    As the COVID-19 public health emergency comes to an end, about half of adults say they would be likely to get an annual COVID-19 booster. Around one in three adults don't think they have ever had COVID-19, nor have they ever tested positive for it, and they primarily attribute this to taking precautions such as avoiding crowds.

  • KFF Global COVID-19 Vaccine Coverage Tool: Current and Projected Coverage

    Interactive

    This interactive tool, which will be updated regularly, shows the share of the population that has received at least one dose of a COVID-19 vaccine by income-level, region, country, and globally. Additionally, using current rates of first dose administration, the tool estimates whether projected coverage levels will meet certain global targets.

  • KFF COVID-19 Vaccine Monitor: January 2023

    Feature

    This survey finds that nearly four-in-ten adults say their households were recently sick with COVID-19, the Flu, or RSV, and news of the viruses is making many more likely to wear masks and take other precautions. It also explores uptake of the new bivalent booster, why many vaccinated adults have not gotten it, and enthusiasm for another shot among those who have.

  • How Much Could COVID-19 Vaccines Cost the U.S. After Commercialization?

    Issue Brief

    This analysis illustrates the potential total cost of Pfizer and Moderna COVID-19 vaccines, based on their publicly-announced expected prices, once they enter the U.S. commercial market. It compares the average price paid by the federal government for the COVID-19 bivalent boosters to the estimated average commercial prices across different scenarios.

  • Half of the Public Would Likely Get an Annual COVID-19 Vaccine Offered Like a Flu Shot

    News Release

    More than three years into the COVID-19 pandemic, about half (53%) the public says they would likely get an annual COVID-19 vaccine if offered similar to an annual flu shot, the latest KFF COVID-19 Vaccine Monitor finds. This includes about a third (32%) who would be “very likely” to do so. The findings provide a window into the potential uptake of an annual COVID-19 vaccine, which the Food and Drug Administration has raised as a…

  • KFF COVID-19 Vaccine Monitor: December 2022

    Feature

    This Vaccine Monitor survey finds that almost three in ten adults now say that parents should be able to decide not to vaccinate their school-age children for measles and other childhood illness, up since 2019 before the COVID-19 pandemic. It also explores uptake of the new bivalent booster, and why many vaccinated adults have not gotten it.

  • COVID-19 Cases, Deaths, and Vaccinations by Race/Ethnicity as of Winter 2022

    Issue Brief

    Over the course of the pandemic, racial disparities in cases and deaths have widened and narrowed. However, overall, Black, Hispanic, and American Indian and Alaska Native (AIAN) people have borne the heaviest health impacts of the pandemic. While Black and Hispanic people were less likely than their White counterparts to receive a vaccine during the initial phases of the vaccination rollout, these disparities have narrowed over time and reversed for Hispanic people.

  • Analysis: There is Significant Variation in State and Local Eligibility Criteria for Monkeypox Vaccines, and Vaccine Information is not Always Accessible

    News Release

    According to a new KFF analysis assessing monkeypox (MPX) vaccine eligibility across the United States, people who are exposed or presumed exposed to MPX are generally eligible to get a vaccine across the country. However, eligibility varies across the United States for certain workers, including laboratory staff and others who might be at increased risk. The analysis examines MPX vaccine eligibility policies, compared to criteria recommended by the Centers for Disease Control and Prevention (CDC),…